Trevi Therapeutics Inc (TRVI)
2.74
-0.09
(-3.18%)
USD |
NASDAQ |
May 21, 15:34
Trevi Therapeutics Shareholders Equity (Quarterly): 72.33M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 72.33M |
December 31, 2023 | 82.55M |
September 30, 2023 | 89.61M |
June 30, 2023 | 95.07M |
March 31, 2023 | 101.73M |
December 31, 2022 | 107.46M |
September 30, 2022 | 109.90M |
June 30, 2022 | 60.52M |
March 31, 2022 | 10.46M |
December 31, 2021 | 17.08M |
September 30, 2021 | 11.38M |
Date | Value |
---|---|
June 30, 2021 | 17.74M |
March 31, 2021 | 23.68M |
December 31, 2020 | 27.28M |
September 30, 2020 | 35.62M |
June 30, 2020 | 40.04M |
March 31, 2020 | 46.80M |
December 31, 2019 | 54.54M |
September 30, 2019 | 60.71M |
June 30, 2019 | 67.70M |
March 31, 2019 | 12.68M |
December 31, 2018 | 6.248M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.46M
Minimum
Mar 2022
109.90M
Maximum
Sep 2022
56.61M
Average
57.53M
Median
Shareholders Equity (Quarterly) Benchmarks
Accuray Inc | 41.08M |
Vanda Pharmaceuticals Inc | 544.00M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 78.56M |
Total Liabilities (Quarterly) | 6.225M |